#1 Clinical Trials Search in Europe

PARECOXIB

Parecoxib (commonly marketed as Dynastat) is a selective COX-2 inhibitor that belongs to the non-steroidal anti-inflammatory drug (NSAID) class. It is unique as the first injectable COX-2 inhibitor developed for acute pain management, particularly in the postoperative setting. This article examines how clinical trials have evaluated parecoxib’s effectiveness in managing pain after various surgical procedures, its opioid-sparing effects, and its safety profile compared to other analgesics. Understanding the role of parecoxib in clinical trials can help patients and healthcare providers make informed decisions about pain management strategies in surgical settings.

Table of Contents

What is Parecoxib?

Parecoxib is a prescription medication that belongs to a class of drugs called COX-2 selective inhibitors, which are a type of non-steroidal anti-inflammatory drugs (NSAIDs). It’s marketed under the brand name Dynastat, and also available as a generic medication called Parestat in some countries [1]. Parecoxib is a water-soluble prodrug, which means it’s inactive until metabolized in the body into its active form, valdecoxib [2].

What makes parecoxib unique is that it’s the first selective COX-2 inhibitor that can be administered intravenously (into a vein) or intramuscularly (into a muscle), making it suitable for situations where oral medications cannot be used [3].

How Parecoxib Works

Parecoxib works by selectively blocking an enzyme called cyclooxygenase-2 (COX-2). This enzyme is responsible for producing substances called prostaglandins that cause inflammation, pain, and fever in the body [4].

Unlike traditional NSAIDs, which block both COX-1 and COX-2 enzymes, parecoxib primarily targets COX-2. This selective action helps reduce pain and inflammation while potentially causing fewer gastrointestinal side effects than traditional NSAIDs [5]. The main benefit of COX-2 inhibitors like parecoxib is that they have minimal inhibition of platelet function and therefore minimal risk of increased bleeding [6].

Medical Uses of Parecoxib

Parecoxib is primarily used for managing moderate to severe post-operative pain. Based on clinical trials, it has been successfully used in various surgical settings:

Post-Surgical Pain Management

  • Breast surgery: Studies have shown parecoxib is effective for pain relief after breast surgeries, including breast biopsies and submuscular breast augmentation [1] [7].
  • Orthopedic procedures: Used after total knee arthroplasty (knee replacement) and other orthopedic surgeries [8].
  • Abdominal surgery: Effective for pain management after various abdominal procedures, including gynecological surgeries [9] [10].
  • Craniotomy: Used to manage pain after brain surgery [6].
  • Laparoscopic procedures: Helps reduce shoulder pain that commonly occurs after laparoscopic surgeries [11].

Other Pain Conditions

  • Renal colic: Used for treating the intense pain caused by kidney stones [5].
  • Catheter-related bladder discomfort: Studies have evaluated its effectiveness in preventing bladder discomfort associated with urinary catheterization [12].
  • Complex Regional Pain Syndrome (CRPS): Some research has explored its use in this chronic pain condition [13].

Additional Benefits

Beyond pain relief, parecoxib has been investigated for:

  • Reducing post-operative shivering: Research has compared its effectiveness to other medications for this purpose [14].
  • Prevention of post-ERCP pancreatitis: Being studied for its potential to prevent inflammation of the pancreas after endoscopic retrograde cholangiopancreatography (ERCP) procedures [3].
  • Reducing emergence delirium: May help reduce confusion and agitation that some elderly patients experience when waking from anesthesia [9].
  • Potentially reducing transition from acute to chronic pain: Some research suggests it might help prevent acute postoperative pain from developing into chronic pain [15].

Effectiveness of Parecoxib

Clinical trials have demonstrated several benefits of parecoxib in pain management:

Pain Relief

Studies show that parecoxib provides effective pain relief comparable to traditional NSAIDs and opioids in many situations. In a trial comparing generic parecoxib (Parestat) to the original formulation (Dynastat), both versions provided the same level of pain relief after breast surgery [1].

Opioid-Sparing Effect

One of the most significant benefits of parecoxib is its ability to reduce the need for opioid pain medications. Multiple studies have shown that patients who receive parecoxib require less morphine or other opioids for pain control [7] [9]. This is particularly important given concerns about opioid dependency and side effects.

For example, in studies of patients undergoing gynecological surgery, those who received parecoxib in addition to epidural analgesia required significantly less morphine than those who received placebo [16].

Rapid Onset

When administered intravenously, parecoxib begins working relatively quickly to provide pain relief, which is valuable in acute post-surgical settings [7].

Duration of Action

Parecoxib is relatively long-acting compared to some other parenteral pain medications, which means fewer doses may be needed [17].

How Parecoxib is Administered

Parecoxib is available as a powder that must be reconstituted (mixed with a liquid) before administration. It’s designed for professional use in hospitals or clinical settings, not for self-administration at home [1] [18].

Routes of Administration

  • Intravenous (IV) injection: Given directly into a vein, either as a quick injection or as an infusion over about 30 minutes [18].
  • Intramuscular (IM) injection: Injected into a muscle, though this route is less commonly used [19].

Dosing

The typical dose for adults is 40mg, given intravenously or intramuscularly [1]. In clinical studies, dosing schedules have included:

  • A single dose before surgery (preemptive analgesia) [17].
  • Multiple doses given at regular intervals (such as every 12 hours) for 1-3 days after surgery [9] [10].
  • Reduced dosing (20mg) for patients with moderate liver impairment [18].

Side Effects and Safety Considerations

Like all medications, parecoxib can cause side effects, though not everyone experiences them [1] [8].

Common Side Effects

  • Nausea and vomiting
  • Dizziness
  • Headache
  • Constipation
  • Changes in blood pressure (increase or decrease)

Less Common Side Effects

  • Edema (swelling)
  • Pruritus (itching)
  • Gastritis (inflammation of the stomach lining)
  • Bronchospasm (tightening of the airways)

Safety Considerations

Several clinical trials have monitored the safety of parecoxib, particularly regarding:

  • Bleeding risk: As a selective COX-2 inhibitor, parecoxib has minimal effect on platelet function, which may make it safer than traditional NSAIDs in surgical settings where bleeding is a concern [6].
  • Kidney function: Studies have monitored kidney function in patients receiving parecoxib [20].
  • Liver function: Researchers have tracked liver enzyme levels to ensure safety [20].
  • Cardiovascular events: Some studies have monitored for cardiovascular side effects [16].

Contraindications

Parecoxib should not be used in certain situations, including:

  • Patients with a history of allergic reactions to parecoxib, valdecoxib, or other NSAIDs
  • Patients with severe heart failure
  • Patients with active gastrointestinal bleeding or peptic ulcer disease
  • Patients with severe kidney or liver impairment
  • Women in the third trimester of pregnancy

Comparison with Other Medications

Several studies have compared parecoxib to other pain medications:

Parecoxib vs. Traditional NSAIDs

  • Compared to ketorolac: Studies have evaluated the efficacy of parecoxib versus ketorolac for preemptive analgesia in spine fusion surgery [21].
  • Compared to flurbiprofen: Research has compared these medications for reducing postoperative shivering [14].
  • Compared to dexketoprofen: Studies have compared these medications for managing pain after cesarean section [22].
  • Compared to indomethacin: Research has evaluated these medications for preventing post-ERCP pancreatitis [3].

Parecoxib vs. Other Analgesics

  • Compared to paracetamol (acetaminophen): Studies have compared these medications for treating renal colic [5].
  • Compared to morphine: Research has compared parecoxib to morphine for managing acute pain in sickle cell disease patients [23].

Combinations

Parecoxib is often used as part of multimodal pain management approaches, in combination with:

  • Opioids: Studies have shown that parecoxib reduces opioid requirements when used together [7] [9].
  • Regional anesthesia: Used alongside techniques like epidural analgesia or femoral nerve blocks [8] [16].
  • Paracetamol (acetaminophen): Often combined for enhanced pain relief [6].
  • Glucocorticoids: Some studies have evaluated combinations with steroids like dexamethasone [24].

Special Populations

Elderly Patients

Parecoxib has been studied specifically in elderly patients, where it has shown efficacy in reducing emergence delirium (confusion after anesthesia) and postoperative pain [9].

Patients with Liver Impairment

In patients with moderate hepatic impairment (Child-Pugh score 7-9), a reduced dose of parecoxib (20mg instead of 40mg) is recommended [18].

Surgical Populations

Different surgical populations may experience different benefits from parecoxib:

  • Breast surgery patients: May benefit from reduced post-operative pain [1] [7].
  • Orthopedic surgery patients: Studies show improved pain control and function [8].
  • Neurosurgical patients: Research has examined benefits for post-craniotomy pain [6].
  • Laparoscopic surgery patients: May experience reduced shoulder pain, which is a common complaint after these procedures [11].
Aspect Details about PARECOXIB in Clinical Trials
Drug Type Selective COX-2 inhibitor non-steroidal anti-inflammatory drug (NSAID)
Administration Routes Intravenous (IV) and Intramuscular (IM) injection
Common Dosing 40mg every 12 hours (standard); 20mg for patients with moderate hepatic impairment
Surgical Applications – Breast surgeries (excision biopsies, augmentation)
– Orthopedic procedures (knee/hip replacement)
– Gynecological procedures
– Craniotomy (brain surgery)
– Thoracic surgery
– Abdominal surgery
– Spinal surgery
Primary Outcomes Measured – Pain scores (VAS, NRS)
– Opioid consumption reduction
– Time to onset of pain relief
– Incidence of moderate-severe pain
Key Benefits – Effective postoperative pain management
– Significant opioid-sparing effects
– Reduced opioid-related side effects
– Option for patients where traditional NSAIDs are contraindicated
– Compatible with multimodal analgesia approaches
Comparison Trials – vs. Placebo: Consistently superior pain relief
– vs. Traditional NSAIDs (ketorolac, dexketoprofen): Similar efficacy with potentially better safety profile
– vs. Opioids: Comparable efficacy for certain pain types with fewer side effects
– Generic vs. Brand name: Bioequivalence studies show similar effects
Innovative Applications – Treatment of catheter-related bladder discomfort
– Prevention of emergence delirium in elderly patients
– Management of post-ERCP pancreatitis
– Treatment of acute renal colic
– Pain management in sickle cell crisis
– Potential role in reducing postoperative shivering
Safety Considerations – Cardiovascular risk with prolonged use
– Renal function monitoring recommended
– Reduced but not eliminated bleeding risk
– Contraindicated in severe heart failure
– Dose adjustment needed in hepatic impairment
– Generally well-tolerated in short-term use

FAQ

  • What is PARECOXIB and how does it work? Parecoxib (often marketed as Dynastat) is a selective COX-2 inhibitor that belongs to the non-steroidal anti-inflammatory drug (NSAID) class. It's unique as the first parenteral (injectable) COX-2 inhibitor available for treating acute pain. Parecoxib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a major role in pain and inflammation, while having minimal effect on COX-1 enzymes that protect the stomach lining and affect platelet function. This selective action helps reduce pain and inflammation with potentially fewer gastrointestinal side effects and bleeding risks compared to traditional NSAIDs.
  • For what types of surgeries has PARECOXIB been studied in clinical trials? Clinical trials have studied parecoxib's effectiveness in multiple surgical settings including: breast surgeries (including breast excision biopsies and submuscular breast augmentation), orthopedic procedures (like total knee arthroplasty and hip replacement), gynecological surgeries (including laparoscopic procedures), abdominal surgeries, craniotomy (brain surgery), thoracic surgeries (including video-assisted thoracoscopic surgery), spine surgeries (posterior lumbar spinal fusion), and hepatic (liver) surgeries. The drug has been evaluated across this wide range of procedures to determine its effectiveness for different types of surgical pain.
  • What are the main benefits of PARECOXIB shown in clinical trials? Clinical trials have demonstrated several key benefits of parecoxib: 1) Effective pain relief comparable to traditional pain medications in multiple surgical settings; 2) Significant opioid-sparing effect, reducing the amount of morphine and other opioids needed after surgery; 3) Decreased incidence of opioid-related side effects like nausea, vomiting, and respiratory depression; 4) Improved postoperative recovery with earlier mobility in some studies; 5) Versatility in administration (can be given intravenously or intramuscularly); and 6) Effectiveness as part of multimodal pain management approaches when combined with other medications like acetaminophen.
  • How does PARECOXIB compare to traditional pain medications in clinical trials? Clinical trials have compared parecoxib to several traditional pain medications with interesting results. When compared to placebo, parecoxib consistently provides superior pain relief across various surgical procedures. In comparison with other NSAIDs like ketorolac, dexketoprofen, and flurbiprofen, parecoxib has shown similar or sometimes superior efficacy with potentially fewer bleeding concerns due to its COX-2 selectivity. In studies comparing parecoxib to opioids like morphine, parecoxib demonstrates comparable pain relief for certain pain types while causing fewer side effects such as nausea, vomiting, respiratory depression, and sedation. However, for very severe pain, opioids may still be more effective. The best results often come from multimodal approaches where parecoxib is used alongside other analgesics.
  • What safety concerns or side effects of PARECOXIB have been identified in clinical trials? Clinical trials have identified several safety considerations with parecoxib: 1) Cardiovascular risks: Like other COX-2 inhibitors, parecoxib may increase the risk of cardiovascular events, particularly with prolonged use; 2) Renal (kidney) effects: Monitoring of kidney function may be necessary, especially in at-risk patients; 3) Bleeding risk: Though less than traditional NSAIDs, there's still some concern in surgical settings; 4) Allergic reactions: Particularly in patients with sulfonamide allergies; 5) Gastrointestinal effects: Though less than traditional NSAIDs, they can still occur; 6) Drug interactions with certain medications; and 7) Contraindications in specific patient populations such as those with severe heart failure, active gastrointestinal bleeding, or advanced kidney disease. The trials generally showed that short-term use for acute postoperative pain has an acceptable safety profile when used in appropriate patients.

Ongoing Clinical Trials on PARECOXIB

  • Study of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

References

  1. https://clinicaltrials.gov/study/NCT07154446
  2. https://clinicaltrials.gov/study/NCT06600282
  3. https://clinicaltrials.gov/study/NCT06623513
  4. https://clinicaltrials.gov/study/NCT01186159
  5. https://clinicaltrials.gov/study/NCT03704623
  6. https://clinicaltrials.gov/study/NCT00455117
  7. https://clinicaltrials.gov/study/NCT00435747
  8. https://clinicaltrials.gov/study/NCT02185924
  9. https://clinicaltrials.gov/study/NCT01221025
  10. https://clinicaltrials.gov/study/NCT02272660
  11. https://clinicaltrials.gov/study/NCT01393925
  12. https://clinicaltrials.gov/study/NCT02729935
  13. https://clinicaltrials.gov/study/NCT01523379
  14. https://clinicaltrials.gov/study/NCT02569905
  15. https://clinicaltrials.gov/study/NCT06721988
  16. https://clinicaltrials.gov/study/NCT01566669
  17. https://clinicaltrials.gov/study/NCT06140238
  18. https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-parecoxib-and-sodium-chloride-for-patients-hospitalized-with-spontaneous-subarachnoid-hemorrhage/
  19. https://clinicaltrials.gov/study/NCT00139646
  20. https://clinicaltrials.gov/study/NCT02204878
  21. https://clinicaltrials.gov/study/NCT01859585
  22. https://clinicaltrials.gov/study/NCT04847024
  23. https://clinicaltrials.gov/study/NCT06315920
  24. https://clinicaltrials.gov/study/NCT01361789